Evaxion AS (EVAX)
3.01
-0.06
(-1.95%)
USD |
NASDAQ |
Oct 12, 15:13
Evaxion Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.044M |
| September 30, 2023 | -4.426M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -8.347M |
| Date | Value |
|---|---|
| December 31, 2021 | -4.325M |
| September 30, 2021 | -6.580M |
| June 30, 2021 | -7.985M |
| March 31, 2021 | -4.366M |
| December 31, 2020 | -4.690M |
| September 30, 2020 | -2.844M |
| June 30, 2020 | -2.371M |
| March 31, 2020 | -3.014M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -26.08M |
| DBV Technologies SA | -49.68M |
| Cellectis SA | -14.59M |
| Akari Therapeutics Plc | -3.112M |
| Ascendis Pharma A/S | 323.81M |